MedPath

Study To Determine Safety & Efficacy Of Autologous Human Platelet Lysate in Androgenetic Alopecia After Hair Transplant

Phase 1
Conditions
Androgenetic Alopecia
Interventions
Biological: Autologous Human Platelet Lysate
Other: Standard hair follicle transplant
Registration Number
NCT01644422
Lead Sponsor
Kasiak Research Pvt. Ltd.
Brief Summary

This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of Human Platelet Lysate (HPL) in subjects with Androgenetic Alopecia undergoing hair transplantation. The study is being conducted at 2 centers in India. The primary endpoints are Increase in Hair Follicle viability after transplant, Improvement in Caliber \& Density of hair and Improvement in Photographic assessment from randomization to end of study. The secondary endpoints are Physicians and Patients self assessment score.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Male subjects, aged between 18 to 50 years (both inclusive) and in general good health
  • Subjects willing to refrain from other AGA treatments during the entire study duration
  • Subjects who are willing to give informed consent and adhere to the study protocol
Exclusion Criteria
  • Subjects aged <18 or > 50 years
  • Subjects with dermatological disorder of scalp that might interfere with study evaluation
  • Subjects on Anti-coagulant therapy
  • Subjects with clinically significant medical or psychiatric disease as determined by the investigator.
  • Subjects unwilling to or unable to comply with the study protocol.
  • Subjects taking concomitant therapy that might interfere with the study results in investigators opinion or participating in another trial in the past 30 days.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study arm AAutologous Human Platelet LysateSubjects will receive hair follicles transplants that are dipped in HPL before transplant
Study arm BAutologous Human Platelet LysateSubjects will receive hair follicles transplants that are dipped in HPL before transplant; followed by one HPL injection one week after transplant
Control arm CStandard hair follicle transplantSubject will receive Standard hair follicle transplant
Primary Outcome Measures
NameTimeMethod
Improvement in Calibre & Density of Hair as assessed by FolliscopeDay 0, Month 2, End of Study - Month 4
Secondary Outcome Measures
NameTimeMethod
Photographic assessmentDay 0, Month 1, Month 2, Month 3, End of Study - Month 4

Trial Locations

Locations (1)

Kasiak Research Pvt Ltd

🇮🇳

Thane, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath